Prosecution Insights
Last updated: July 17, 2026
Application No. 18/080,434

ULTRASOUND ANALYSIS METHOD AND SYSTEM PERFORMING THE SAME

Final Rejection §103§112§Other
Filed
Dec 13, 2022
Examiner
BRUCE, FAROUK A
Art Unit
3797
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Starshot Pte. Ltd.
OA Round
4 (Final)
47%
Grant Probability
Moderate
5-6
OA Rounds
10m
Est. Remaining
85%
With Interview

Examiner Intelligence

Grants 47% of resolved cases
47%
Career Allowance Rate
99 granted / 209 resolved
-22.6% vs TC avg
Strong +37% interview lift
Without
With
+37.4%
Interview Lift
resolved cases with interview
Typical timeline
4y 5m
Avg Prosecution
43 currently pending
Career history
263
Total Applications
across all art units

Statute-Specific Performance

§101
0.9%
-39.1% vs TC avg
§103
85.3%
+45.3% vs TC avg
§102
2.3%
-37.7% vs TC avg
§112
0.7%
-39.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 209 resolved cases

Office Action

§103 §112 §Other
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Arguments Applicant’s arguments, see pages 7-18 of Applicant’s responses filed 03/26/2026, with respect to the 35 U.S.C. 112(d) rejection of claim 13 and the 35 U.S.C. 103 rejections of claims 1-2,5-12,14 and 17-20 have been fully considered and are persuasive. The rejections have been withdrawn. Applicant’s Representative was contacted regarding potential amendments to place the claims in condition for allowance. Applicant’s Representative indicated that an office action indicating issues with the claim would allow a more careful consideration of the status of the claims. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-2,5-12,14 and 17-20 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 1 recites “wherein, during a target object analysis stage, the plurality of planar ultrasound signals are emitted to the target object at different angles, the target object reflects the plurality of scattered echo signals at different angles, and the controller reconstructs and combines the plurality of scattered echo signals from different angles to obtain the plurality of ultrasound images of the target object formed by interference of the scattered echo signals from different angles”. The limitation alludes to “different angles” for emitting the plurality of planar ultrasound signals and “different angles” for receiving and reconstructing the plurality of scattered echo signals to form ultrasound images. However, the limitation fails to clarify if the “different angles” for emitting the plurality of planar ultrasound signals differs or is the same as the “different angles” for receiving and reconstructing the plurality of scattered echo signals to form ultrasound images. Withdrawn Claim Rejections - 35 USC § 103 Pursuant of Applicant’s amendments filed 03/26/2026, the rejection of claims 1-2,5-12,14 and 17-20 under 35 U.S.C. have been withdrawn. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. US 20180177491 A1 teaches a transcranial ultrasound system that converts convergent spherical ultrasound waves into planar waves. Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Farouk A Bruce whose telephone number is (408)918-7603. The examiner can normally be reached Mon-Fri 8-5pm PST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Christopher Koharski can be reached on (571) 272-7230. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /FAROUK A BRUCE/ Examiner, Art Unit 3797 /CHRISTOPHER KOHARSKI/ Supervisory Patent Examiner, Art Unit 3797
Read full office action

Prosecution Timeline

Show 3 earlier events
Jun 28, 2025
Final Rejection (signed) — §103, §112, §Other
Aug 29, 2025
Final Rejection mailed — §103, §112, §Other
Oct 29, 2025
Request for Continued Examination
Nov 06, 2025
Response after Non-Final Action
Dec 30, 2025
Non-Final Rejection mailed — §103, §112, §Other
Mar 26, 2026
Response Filed
Jun 05, 2026
Examiner Interview (Telephonic)
Jun 17, 2026
Final Rejection mailed — §103, §112, §Other (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12678262
EXAMINATION MARKER AND EXAMINATION MARKER SET
2y 8m to grant Granted Jul 14, 2026
Patent 12672936
SUPPORT ARM FOR MEDICAL DEVICE SUPPORT SYSTEM
6y 7m to grant Granted Jul 07, 2026
Patent 12661205
NEEDLE LOCALIZATION REFLECTORS, SYSTEMS, AND METHODS
3y 11m to grant Granted Jun 23, 2026
Patent 12636364
ARRANGEMENT FOR VAPORIZING NANOAGENTS SUITABLE FOR THERAPY INSIDE THE HUMAN BODY AND DEVICE COMPRISING THE ARRANGEMENT
2y 5m to grant Granted May 26, 2026
Patent 12629126
METHOD FOR PROVIDING CONTROL SETTINGS, USE OF THE CONTROL SETTINGS AND OVERALL MEDICAL SYSTEM
3y 5m to grant Granted May 19, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

5-6
Expected OA Rounds
47%
Grant Probability
85%
With Interview (+37.4%)
4y 5m (~10m remaining)
Median Time to Grant
High
PTA Risk
Based on 209 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month